A machine learning-based framework for Predicting Treatment Failure in tuberculosis: A case study of six countries.
Muhammad Asad1, Azhar Mahmood1, Muhammad Usman1
1Predictive Analytics Lab, Shaheed Zulfikar Ali Bhutto Institute of Science and Technology (SZABIST), Islamabad, Pakistan.
Tuberculosis (Edinburgh, Scotland)
|August 4, 2020
Summary
Machine learning identified key features contributing to tuberculosis treatment failure. This research helps understand why treatments fail, aiming to reduce deaths from this deadly disease.
Area of Science:
- Medical research
- Data science in healthcare
- Public health
Background:
- Tuberculosis (TB) is a leading cause of death globally, with treatment failure being a significant contributor.
- The underlying reasons for TB treatment failure remain largely unknown, leading to increasing mortality rates.
- Machine learning and data analytics offer potential for identifying factors associated with disease outcomes.
Purpose of the Study:
- To identify features strongly correlated with tuberculosis treatment failure using feature selection techniques.
- To validate identified features using various classification algorithms.
- To analyze demographic-based feature associations in high-burden countries.
Main Methods:
- Utilized a real-life patient dataset from six high-burden countries: Azerbaijan, Belarus, Georgia, India, Moldova, and Romania.
- Applied feature selection techniques to identify critical attributes linked to treatment failure.
- Employed multiple classification algorithms for feature validation.
Main Results:
- Achieved an average accuracy of 78% on the combined dataset.
- Attained a higher accuracy of 92% specifically for Romania's data.
- Demonstrated that the identified features significantly influence treatment failure outcomes.
Conclusions:
- The study successfully identified key features associated with tuberculosis treatment failure.
- These findings can aid in timely identification of at-risk patients, potentially improving treatment success rates.
- The insights gained can inform public health strategies in high-burden regions to combat TB mortality.
Related Concept Videos
Pulmonary Tuberculosis V
439
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
439
Pulmonary Tuberculosis I
701
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
701
Pulmonary Tuberculosis IV
392
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
392
Pulmonary Tuberculosis II
1.2K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.2K
Pulmonary Tuberculosis III
761
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
761


